PMI Results
 |
|
A mother and her daughter are protected by a long-lasting insecticide-treated mosquito net in Senegal.
Source: Maggie Hallahan Photography |
The past decade has seen unprecedented progress in malaria control efforts in most sub-Saharan African countries. As countries have scaled-up insecticide-treated mosquito nets (ITNs), indoor residual spraying (IRS), improved diagnostic tests, and highly effective antimalarial drugs, mortality in children under five years of age has fallen dramatically. It is now clear that the cumulative efforts and funding by the President’s Malaria Initiative, national governments, The Global Fund to Fight AIDS, Tuberculosis, and Malaria, the World Bank and many other donors are working: the risk of malaria is declining. According to the World Health Organization’s 2012 World Malaria Report, the estimated annual number of global malaria deaths has fallen by more than one-third – from about 985,000 in 2000 to about 660,000 in 2010.
This page summarizes the progress PMI has achieved after seven years of implementation. For more details, please access the PMI Seventh Annual Report, April 2013 [PDF, 4.55MB].
Click on any of the charts below to see a larger image.
Progress After Seven Years of Implementation
 |
- The data reported in this table are up-to-date as of September 30, 2012, and include all PMI focus countries and the Greater Mekong Subregion. In addition, during FY 2012, the U.S. Government provided support for malaria prevention and control activities in other countries. For data by country, see Appendix 2 of the President’s Malaria Initiative 7th Annual Report to Congress.
- For Year 6, PMI transitioned from a calendar year to a fiscal year reporting schedule.
- A cumulative count of people protected by IRS is not provided because most areas were sprayed on more than one occasion.
- Amount distributed to health facilities.
- These figures include health workers who were trained in focused antenatal care in Rwanda, where IPTp is not national policy.
- A cumulative count of individual health workers trained is not provided because some health workers were trained on more than one occasion.
|
Impact on Mortality of Children Under Five Years of Age
- In all 12 PMI focus countries with baseline and follow-up nationwide household surveys, substantial reductions in all-cause mortality (ranging from 16 to 50 percent) have been documented in children under the age of five.
 |
| The PMI focus countries included in this graph have at least two data points from nationwide household surveys that measure mortality in children under the age of five. These data are drawn from Demographic and Health Surveys, Multiple Indicator Cluster Surveys, and, in a small number of cases, from Malaria Indicator Surveys with expanded sample sizes. In some countries, two surveys were conducted within the same period. In Angola, both estimates for under-five mortality are derived from the 2011 Malaria Indicator Survey. |
Coverage of Malaria Interventions
In countries where at least two comparable nationwide household surveys have been conducted since the launch of PMI activities:
- Household ownership of at least one ITN increased from an average* of 36 to 60 percent.
|
| The PMI focus countries included in this graph have at least two data points for ITN ownership from nationwide household surveys (Demographic and Health Surveys, Malaria Indicator Surveys, or Multiple Indicator Cluster Surveys). In some countries, two surveys were conducted within the same period. |
- Usage of an ITN increased from an average* of 22 to 43 percent for children under five years and about the same for pregnant women.
 |
| The PMI focus countries included in this graph have at least two data points for ITN use among children under five from nationwide household surveys (Demographic and Health Surveys, Malaria Indicator Surveys, or Multiple Indicator Cluster Surveys). In some countries, two surveys were conducted during the same period. |
- The proportion of pregnant women who received two or more doses of intermittent preventive treatment for pregnant women (IPTp2) for the prevention of malaria increased from an average* of 15 to 29 percent.
 |
| The PMI focus countries included in this graph have at least two data points for IPTp2 from nationwide household surveys (Demographic and Health Surveys, Malaria Indicator Surveys, Malaria Indicator Surveys Cluster Surveys). In some countries, two surveys were conducted within the same period. IPTp2 is defined as at least two doses of SP during the last pregnancy, with at least one dose given during an antenatal clinic visit. |
*defined as the median of the percent coverage
[Return to top]